Biora Therapeutics (BIOR) has reached an agreement with certain of its prepetition creditors to provide financing to support a chapter 11 sale process, which will ultimately lead to a strengthened ...

Sale process will help enable next stage of product development Secures up to $10.25 million in new financing to support ongoing business operations SAN DIEGO, Dec. 30, 2024 (GLOBE NEWSWIRE) -- Biora ...

Biora Therapeutics, a reputable biotech firm listed on the NASDAQ under the ticker BIOR, recently made waves in the financial world by voluntarily filing a petition on December 27, 2024, under Chapter ...

Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter ...

Biora Therapeutics, a biotech company developing smart pill-based therapeutic platforms, has reached an agreement with certain of its prepetition creditors (the “Lenders”) to provide financing to ...

Biora Therapeutics, Inc. (NASDAQ:BIOR – Get Free Report) shares fell 11.6% during trading on Monday . The stock traded as low as $0.42 and last traded at $0.53. 18,311 shares were traded during ...

Biora Therapeutics shares are trading lower by 45% during Tuesday's session. The company announced that it will be delisted from Nasdaq. Biora Therapeutics says trading of the company's securities ...

SAN DIEGO, CA - Biora Therapeutics, Inc. (NASDAQ:BIOR), a pharmaceutical company with a market capitalization of just $6 million, is set to be delisted from The Nasdaq Global Market following a ...

Biora Therapeutics shares are trading lower by 45% during Tuesday's session. The company announced that it will be delisted from Nasdaq.

Biora Therapeutics (BIOR) has reached an agreement with certain of its prepetition creditors to provide financing to support a chapter 11 sale process, which will ultimately lead to a strengthened ...